Improving the Quality, Safety and Value of Patient Care through Evidence-based Practice:
A Multidisciplinary Regional Forum
Program Sponsors / Organizers
The University of Pennsylvania Health System (UPHS) Center for Evidence-based Practice is hosting a multidisciplinary forum to explore how payors, providers, researchers, policymakers and the biomedical industry can work together to improve the quality, safety and value of patient care in the Philadelphia region through evidence-based practice.
- To explore how medical evidence is used in different sectors of our healthcare system (e.g., how payors use evidence in coverage decisions; how the biomedical industry uses evidence in decisions to conduct post-marketing studies; how policymakers use evidence in decisions regarding funding, publishing, and performance measure development).
- To explore how different healthcare system sectors might work together using evidence as a common basis to improve the quality and value of patient care.
- To brainstorm how we might start to develop a common agenda to accomplish this in the Philadelphia region.
The forum is organized into three sessions, each of which will address a separate conference objective. The first session "Finding Common Ground in Evidence" examines how different health care sectors incorporate evidence into their daily decisions and operations. The second session "Applying What Works and Measuring Success" examines how these different types of organizations might work with health care providers to improve patient care quality, safety and value through evidence-based practice. The final session "Moving Forward in Our Region" explores how the different sectors of our regional healthcare system can collaborate to advance evidence-based practice, using the issue of transitions of care as a focal point. Each session will open with a brief topic overview, followed by an interactive panel discussion addressing targeted questions, and ending with extensive audience participation through Q&A.
The audience of the forum will be limited to regional healthcare leaders, including executive and medical leaders in payor, purchaser, provider, policymaking and biomedical industry organizations. Panels will consist of national health care leaders who will serve as resources for ideas and discussion among the audience of regional healthcare leaders.
Back to top
- David Blumenthal, MD, MPP, Director, Institute for Health Policy and Samuel O. Their Professor of Medicine, Harvard Medical School
- Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality
- L. Gregory Pawlson, MD, MPH, Executive Vice President, National Committee for Quality Assurance
- Donald F. Schwarz, MD, MPH, MBA, Deputy Mayor of Health and Opportunity and Health Commissioner for the City of Philadelphia
- Harold C. Sox, MD, Editor, Annals of Internal Medicine
- Troyen Brennan, MD, MPH, Chief Medical Officer, Aetna
- Allan M Korn, MD, Chief Medical Officer, Blue Cross Blue Shield Association
- I. Steven Udvarhelyi, MD, Senior Vice President and Chief Medical Officer, Independence Blue Cross
- Peter Juhn, MD, MPH, Executive Medical Director, Health Policy and EBM, Johnson & Johnson
- Newell McElwee, PharmD, MSPH, Senior Director, Pfizer
- David Sugano, DrPH, Vice President, Health Outcomes and Economics, Schering-Plough
- Steven Teutsch, MD, MPH, Executive Director, Outcomes Research and Management, Merck
By initiating a broad dialogue with all parties around evidence-based practice, medical centers can begin to build relationships and infrastructures to support and improve the quality, safety and value of patient care. In this vein, the UPHS Office of the CMO in July 2006 limited on-site industry marketing activities while increasing collaboration with industry on developing medical evidence and facilitating evidence based medical care. A newly developed UPHS Center for Evidence-Based Practice summarizes scientific evidence for UPHS decision making about high impact drugs, devices and processes of care, and is charged with building evidence-based collaborative enterprises with industry and payors.
Back to top